Literature DB >> 34321625

Protean role of epigenetic mechanisms and their impact in regulating the Tregs in TME.

A S Smiline Girija1.   

Abstract

Constitutive expression of Foxp3+ Tregs in the tumor microenvironment (TME) specifically renders immune suppression in the tumor tissues. Being highly stable and self-tolerant, Tregs may be influenced by various epigenetic-associated mechanisms while exhibiting their functions. DNA methylation, histone acetylation, epigenetic silencing, alteration in chromatin networks, etc., are some of the main factors underlying the epigenetic-based Treg cell functional modulations in the TME. The possible reasons on why these epigenetic modulations should be specifically targeted are thus discussed, so that enhanced anti-tumor immunity in TME can be achieved.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34321625     DOI: 10.1038/s41417-021-00371-z

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.854


  38 in total

1.  Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.

Authors:  Christel Devaud; Jennifer A Westwood; Michele Wl Teng; Liza B John; Carmen Sm Yong; Connie Pm Duong; Mark J Smyth; Phillip K Darcy; Michael H Kershaw
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

2.  Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.

Authors:  Sameer A Siddiqui; Xavier Frigola; Sandra Bonne-Annee; Maria Mercader; Susan M Kuntz; Amy E Krambeck; Shomik Sengupta; Haidong Dong; John C Cheville; Christine M Lohse; Christopher J Krco; W Scott Webster; Bradley C Leibovich; Michael L Blute; Keith L Knutson; Eugene D Kwon
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

3.  Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

Authors:  Lars A Ormandy; Tina Hillemann; Heiner Wedemeyer; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

4.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.

Authors:  Rafal Matkowski; Iwona Gisterek; Agnieszka Halon; Aleksandra Lacko; Krzysztof Szewczyk; Urszula Staszek; Marek Pudelko; Bartlomiej Szynglarewicz; Jolanta Szelachowska; Andrzej Zolnierek; Jan Kornafel
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

6.  Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

Authors:  Amy B Heimberger; Mohamed Abou-Ghazal; Chantal Reina-Ortiz; David S Yang; Wei Sun; Wei Qiao; Nobuyoshi Hiraoka; Gregory N Fuller
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

7.  Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

Authors:  Paul Salama; Michael Phillips; Fabienne Grieu; Melinda Morris; Nik Zeps; David Joseph; Cameron Platell; Barry Iacopetta
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

8.  Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.

Authors:  Udaya K Liyanage; Todd T Moore; Hong-Gu Joo; Yoshiyuki Tanaka; Virginia Herrmann; Gerard Doherty; Jeffrey A Drebin; Steven M Strasberg; Timothy J Eberlein; Peter S Goedegebuure; David C Linehan
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

9.  Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.

Authors:  James F Curtin; Marianela Candolfi; Tamer M Fakhouri; Chunyan Liu; Anderson Alden; Matthew Edwards; Pedro R Lowenstein; Maria G Castro
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

Review 10.  Treg and CTLA-4: two intertwining pathways to immune tolerance.

Authors:  Lucy S K Walker
Journal:  J Autoimmun       Date:  2013-07-10       Impact factor: 7.094

View more
  2 in total

1.  The expression landscape of FOXP3 and its prognostic value in breast cancer.

Authors:  Jingping Li; Xiangmei Zhang; Beichen Liu; Chao Shi; Xindi Ma; Shuguang Ren; Xiaohan Zhao; Yunjiang Liu
Journal:  Ann Transl Med       Date:  2022-07

2.  Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.

Authors:  Wenhao Xu; Wenkai Zhu; Xi Tian; Wangrui Liu; Yuanyuan Wu; Aihetaimujiang Anwaier; Jiaqi Su; Shiyin Wei; Yuanyuan Qu; Hailiang Zhang; Dingwei Ye
Journal:  Front Cell Dev Biol       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.